Assessment of T Regulatory Cells and Expanded Profiling of Autoantibodies May Offer Novel Biomarkers for the Clinical Management of Systemic Sclerosis and Undifferentiated Connective Tissue Disease
Table 3
Frequency of reactivity to nuclear, nucleolar, or cytoplasmic antigens.